Patients With Interstitial Lung Disease

Prospective Observational Study of Patients With Interstitial Lung Disease (RESPIRARE)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06645977

Acronym

RESPIRARE

Enrollment

1200

Registered

2024-10-17

Start date

2024-04-01

Completion date

2025-04-04

Last updated

2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Brief summary

Prospective monocentric collection of data from adult patients with interstitial lung disease (ILD), to provide real-world data on current patient management at the ILD clinic.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>= 18 years * Diagnosis of ILD, according to international guidelines.

Exclusion criteria

* Inability to give informed consent.

Design outcomes

Primary

Measure	Time frame
Prevalce ILD	5 years

Countries

Italy

Contacts

Primary ContactLuca Richeldi

luca.richeldi@policlinicogemelli.it0630157857

Outcome results